vs
Side-by-side financial comparison of Aris Mining Corp (ARMN) and CytoMed Therapeutics Ltd (GDTC). Click either name above to swap in a different company.
Aris Mining Corp is the larger business by last-quarter revenue ($151.1K vs $115.4K, roughly 1.3× CytoMed Therapeutics Ltd).
Endeavour Mining plc is a multinational mining company that owns and operates gold mines in Côte d'Ivoire, Burkina Faso and Senegal. The company is headquartered in London, England, and is listed on the London Stock Exchange. It is a constituent of the FTSE 100 Index.
CytoMed Therapeutics Ltd is a clinical-stage biopharmaceutical company focused on developing innovative allogeneic chimeric antigen receptor (CAR-T) cell therapies for treating hematological malignancies and solid tumors. It primarily serves global oncology patient populations and advances candidates targeting unmet medical needs in the immuno-oncology segment.
ARMN vs GDTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.1K | $115.4K |
| Net Profit | $20.5K | — |
| Gross Margin | 44.9% | — |
| Operating Margin | 30.0% | — |
| Net Margin | 13.6% | — |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.1K | $-855.3K |
| Free Cash FlowOCF − Capex | — | $-855.4K |
| FCF MarginFCF / Revenue | — | -741.5% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 4.82× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.1K | — | ||
| Q2 25 | — | $-855.3K |
| Q4 25 | — | — | ||
| Q2 25 | — | $-855.4K |
| Q4 25 | — | — | ||
| Q2 25 | — | -741.5% |
| Q4 25 | — | — | ||
| Q2 25 | — | 0.0% |
| Q4 25 | 4.82× | — | ||
| Q2 25 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
